Recognizing the Sources of Interference with Immunoassays
MedSun: Newsletter #25, June 2008

Amitava Dasgupta, PhD, DABCC
American Association for Clinical Chemistry - Clinical Laboratory News

Therapeutic drug monitoring (TDM) has improved patient care but studies suggest that improvements can be made. Until superior, less time-consuming methods are available, laboratorians need to be proactive in educating clinicians about the limitations of assays for certain therapeutic drugs. Implementing these programs requires a major commitment and resources from the lab. To be successful, laboratorians need to provide clinicians with ongoing education, such as bulletins and newsletters, to keep them current with information about the assays.

Additional Information:

Recognizing the Sources of Interference with Immunoassays. Amitava Dasgupta, PhD, DABCC. American Association for Clinical Chemistry - Clinical Laboratory News. April 2008.
http://www.aacc.org/publications/cln/2008/april/Pages/series_0408.aspx


MedSun Newsletters are available at www.fda.gov/cdrh/medsun